-
EP2229385
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2229385
| EP2229385 - Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same [Right-click to bookmark this link] | |||
| Former [2010/38] | BENZIMIDAZOLEDIHYDROTHIADIAZINONE DERIVATIVES AS FRUCTOSE-1,6-BISPHOSPHATASE INHIBITORS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | ||
| [2015/09] | Status | The application is deemed to be withdrawn Status updated on 06.11.2015 Database last updated on 19.07.2024 | Most recent event Tooltip | 06.11.2015 | Application deemed to be withdrawn | published on 09.12.2015 [2015/50] | Applicant(s) | For all designated states Merck Patent GmbH Frankfurter Strasse 250 64293 Darmstadt / DE | [2010/38] | Inventor(s) | 01 /
BOTTON, Gérard 9bis rue du Haras F-78530 Buc / FR | 02 /
LERICHE, Caroline 7 rue Antoine Chantin F-75014 Paris / FR | 03 /
ARBELLOT DE VACQUEUR, Annick 27 rue des Tiers F-91640 Fontenay les Briis / FR | 04 /
AUDET, Annick 14 chemin du Parc F-91630 Leudeville / FR | 05 /
GLEITZ, Johannes Schuknechtstrasse 52 64289 Darmstadt / DE | [2010/38] | Application number, filing date | 08848918.2 | 13.10.2008 | [2010/38] | WO2008EP08631 | Priority number, date | DE200710291349 | 12.11.2007 Original published format: DE102007291349 | [2010/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009062576 | Date: | 22.05.2009 | Language: | EN | [2009/21] | Type: | A2 Application without search report | No.: | EP2229385 | Date: | 22.09.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.05.2009 takes the place of the publication of the European patent application. | [2010/38] | Search report(s) | International search report - published on: | EP | 23.07.2009 | Classification | IPC: | C07D417/04, C07D417/14, A61K31/54 | [2010/38] | CPC: |
C07D417/14 (EP,US);
A61P13/12 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P5/50 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07D417/04 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/38] | Title | German: | Benzimidazoldihydrothiadiazinon-Derivate als Fructose-1,6-Bisphosphatase-Hemmer und ihre pharmazeutischen Zusammensetzungen | [2015/10] | English: | Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same | [2015/09] | French: | Dérivés de benzimidazole-dihydrothiadiazinone en tant qu' inhibiteurs de la fructose-1,6-bisphosphatase, et compositions pharmaceutiques les comprenant | [2015/09] |
| Former [2010/38] | BENZIMIDAZOLDIHYDROTHIADIAZINON-DERIVATE ALS FRUCTOSE-1,6-BISPHOSPHATASE-HEMMER UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAMIT | ||
| Former [2010/38] | BENZIMIDAZOLEDIHYDROTHIADIAZINONE DERIVATIVES AS FRUCTOSE-1,6-BISPHOSPHATASE INHIBITORS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | ||
| Former [2010/38] | NOUVEAUX DÉRIVÉS DE BENZIMIDAZOLE-DIHYDROTHIADIAZINONE EN TANT QUE DES INHIBITEURS DE LA FRUCTOSE-1,6-BISPHOSPHATASE, ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT | Entry into regional phase | 07.04.2010 | National basic fee paid | 07.04.2010 | Designation fee(s) paid | 07.04.2010 | Examination fee paid | Examination procedure | 07.04.2010 | Examination requested [2010/38] | 02.08.2010 | Amendment by applicant (claims and/or description) | 21.01.2011 | Despatch of a communication from the examining division (Time limit: M04) | 08.04.2011 | Reply to a communication from the examining division | 24.11.2014 | Despatch of a communication from the examining division (Time limit: M04) | 09.01.2015 | Reply to a communication from the examining division | 06.02.2015 | Communication of intention to grant the patent | 17.06.2015 | Application deemed to be withdrawn, date of legal effect [2015/50] | 23.07.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2015/50] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.01.2011 | Fees paid | Renewal fee | 12.10.2010 | Renewal fee patent year 03 | 11.10.2011 | Renewal fee patent year 04 | 11.10.2012 | Renewal fee patent year 05 | 14.10.2013 | Renewal fee patent year 06 | 14.10.2014 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP0294647 (MERCK PATENT GMBH [DE]) [A] 1,19* abstract *; | JPH07101954 [ ] (KIRIN BREWERY); | [A]WO9914239 (FORSSMANN WOLF GEORG [DE], et al) [A] 1,19-23 * page 7, paragraph 4; claims 1,3,28,33 *; | [A] - ISHITANI, TOSHITERU ET AL, "Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS , 298(2), 613-622 CODEN: JPETAB; ISSN: 0022-3565, (2001), XP002477494 [A] 1,19-22 * abstract * | [A] - SOGA, HIROSHI ET AL, "Preparation and formulation of benzimidazole derivatives for treatment of heart failure", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1995:855982, URL: STN, XP002477495 [A] 1,19 * abstract * |